换一批
换一批Dominantly inherited micro-satellite instable cancer - the four Lynch syndromes - an EHTG, PLSD position statement.
作者：
Pal,Møller [1]
;
Toni T,Seppälä [2]
;
Aysel,Ahadova [3]
;
Emma J,Crosbie [4]
;
Elke,Holinski-Feder [5]
;
Rodney,Scott [6]
;
Saskia,Haupt [7]
;
Gabriela,Möslein [8]
;
Ingrid,Winship [9]
;
Sanne W Bajwa-Ten,Broeke [10]
;
Kelly E,Kohut [11]
;
Neil,Ryan [12]
;
Peter,Bauerfeind [13]
;
Laura E,Thomas [14]
;
D Gareth,Evans [15]
;
Stefan,Aretz [16]
;
Rolf H,Sijmons [17]
;
Elizabeth,Half [18]
;
Karl,Heinimann [19]
;
Karoline,Horisberger [20]
;
Kevin,Monahan [21]
;
Christoph,Engel [22]
;
Giulia Martina,Cavestro [23]
;
Robert,Fruscio [24]
;
Naim,Abu-Freha [25]
;
Levi,Zohar [26]
;
Luigi,Laghi [18]
;
Lucio,Bertario [27]
;
Bernardo,Bonanni [28]
;
Maria Grazia,Tibiletti [29]
;
Leonardo S,Lino-Silva [30]
;
Carlos,Vaccaro [31]
;
Adriana Della,Valle [32]
;
Benedito Mauro,Rossi [33]
;
Leandro Apolinário,da Silva [34]
;
Ivana Lucia,de Oliveira Nascimento [35]
;
Norma Teresa,Rossi [36]
;
Tadeusz,Dębniak [37]
;
Jukka-Pekka,Mecklin [38]
;
Inge,Bernstein [39]
;
Annika,Lindblom [40]
;
Lone,Sunde [41]
;
Sigve,Nakken [42]
;
Vincent,Heuveline [43]
;
John,Burn [44]
;
Eivind,Hovig [45]
;
Matthias,Kloor [46]
;
Julian R,Sampson [47]
;
Mev,Dominguez-Valentin [48]
;
Prospective Lynch Syndrome Database (www.plsd.eu) and The European Hereditary Tumour Group (www.ehtg.org) [49]
作者单位：
Department of Tumor Biology, Institute of Cancer Research, Oslo University Hospital, PO Box 4950, 0424, NydalenOslo, Norway. moller.pal@gmail.com.
[1]
Faculty of Medicine and Health Technology, Cancer Centre, Tampere University and Tays, Tampere University Hospital, Tampere, Finland.
[2]
Department of Gastrointestinal Surgery, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
[3]
Applied Tumor Genomics, Research Program Unit, University of Helsinki, Helsinki, Finland.
[4]
Department of Applied Tumour Biology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
[5]
Clinical Operation Unit Applied Tumour Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
[6]
Molecular Medicine Partnership Unit (MMPU), European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
[7]
Gynaecological Oncology Research Group, Manchester University NHS Foundation Trust, Manchester, UK.
[8]
Division of Cancer Sciences, University of Manchester, Manchester, UK.
[9]
Medizinische Klinik Und Poliklinik IV, Klinikum Der Universität München, Campus Innenstadt, 80336, Munich, Germany.
[10]
Center of Medical Genetics, 80335, Munich, Germany.
[11]
Hunter Medical Research Institute, University of Newcastle, New Lambton, NSW, 2305, Australia.
[12]
Engineering Mathematics and Computing Lab (EMCL), Interdisciplinary Center for Scientific Computing (IWR), Heidelberg University, Heidelberg, Germany.
[13]
Data Mining and Uncertainty Quantification (DMQ), Heidelberg Institute for Theoretical Studies (HITS), Heidelberg, Germany.
[14]
Surgical Center for Hereditary Tumors, Academic Hospital University, Ev. Bethesda Khs Duisburg, Düsseldorf, Germany.
[15]
Genomic Medicine, The Royal Melbourne Hospital, Melbourne, Australia.
[16]
Department of Medicine, University of Melbourne, Melbourne, Australia.
[17]
Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
[18]
Centre for Psychosocial Research in Cancer, Health Sciences, University of Southampton, Southampton, UK.
[19]
Medical School, University of Edinburgh, Edinburgh, UK.
[20]
Department of Gynaecology Oncology, Royal Infirmary of Edinburgh, Edinburgh, UK.
[21]
Hirslanden clinic, St.Anna Str. 36, 6006, Luzern, Switzerland.
[22]
Institute of Life Science, Swansea University, Swansea, SA28PP, UK.
[23]
Manchester Centre for Genomic Medicine, Division of Evolution Infection and Genomic Sciences, University of Manchester, Manchester, M13 9WL, UK.
[24]
Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.
[25]
National Center for Hereditary Tumor Syndromes, University Hospital Bonn, 53127, Bonn, Germany.
[26]
Gastrointestinal Cancer Prevention Unit, Gastroenterology Department, Rambam Health Care Campus, Haifa, Israel.
[27]
Medical Genetics, Institute for Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
[28]
Department of General, Visceral and Transplatation Surgery, University Hospital of Mainz, Mainz, Germany.
[29]
Lynch Syndrome & Family Cancer Clinic, Centre for Familial Intestinal Cancer, St Mark's Hospital, London, HA1 3UJ, Harrow, UK.
[30]
Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, 04107, Leipzig, Germany.
[31]
Gastroenterology and Gastrointestinal Endoscopy Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, 20132, Milan, Italy.
[32]
Clinic of Obstetrics and Gynecology, Department of Medicine and Surgery, University of Milan-Bicocca, Fondazione IRCCS San Gerardo, Monza, Italy.
[33]
Soroka University Medical Center, Ben-Gurion University of the Negev, Beer Sheva, Israel.
[34]
Service High Risk GI Cancer Gastroenterology, Department Rabin Medical Center, Rabin, Israel.
[35]
Laboratory of Molecular Gastroenterology, IRCCS Humanitas Research Hospital, Parma, Italy.
[36]
Department of Medicine and Surgery, University of Parma, Parma, Italy.
[37]
Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology, Fondazione IRCCS Instituto Nazionale dei Tumori, IRCCS, 20141, Milan, Italy.
[38]
Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141, Milan, Italy.
[39]
Ospedale di Circolo ASST Settelaghi, Università dell'Insubria, Centro di Ricerca tumori eredo-familiari, Varese, Italy.
[40]
Surgical Pathology, Instituto Nacional de Cancerologia, Mexico City, Mexico.
[41]
Instituo Medicina Translacional e Ingenieria Biomedica - Hospital Italiano Bs As. - CONICET, Buenos Aires, Argentina.
[42]
Hospital Central de las Fuerzas Armadas, Grupo Colaborativo Uruguayo, Investigación de Afecciones Oncológicas Hereditarias (GCU), Montevideo, Uruguay.
[43]
Hospital Sírio-Libanês, São Paulo, Brasil.
[44]
Hospital Universitário Oswaldo Cruz/Universidade de Pernambuco, Recife, Brazil.
[45]
Instituto de Ciência da Saúde da UFBA/NOB-Grupo Oncoclinicas, Salvador, Brazil.
[46]
Fundación para el Progreso de la Medicina y Sanatorio Allende, Córdoba, Argentina.
[47]
Department of Genetics and Pathology, Pomeranian Medical University, ul. Unii Lubelskiej 1, 71-252, Szczecin, Poland.
[48]
Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland.
[49]
Department of Surgery, Central Finland Health Care District, Jyväskylä, Finland.
[50]
Department of Surgical Gastroenterology, Aalborg University Hospital, Aalborg University, 9000, Aalborg, Denmark.
[51]
Department of Clinical Medicine, Aalborg University Hospital, Aalborg University, 9000, Aalborg, Denmark.
[52]
The Danish HNPCC-register, Hvidovre Hospital, Hvidovre, Denmark.
[53]
Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76, Stockholm, Sweden.
[54]
Clinical Genetics, Karolinska University Hospital, Solna, Sweden.
[55]
Department of Clinical Genetics, Aalborg University Hospital, 9000, Aalborg, Denmark.
[56]
Department of Biomedicine, Aarhus University, DK-8000, Aarhus, Denmark.
[57]
Department of Tumor Biology, Institute of Cancer Research, Oslo University Hospital, PO Box 4950, 0424, NydalenOslo, Norway.
[58]
Centre for bioinformatics, University of Oslo, Postbox 1080 Blindern, 0316, Oslo, Norway.
[59]
Centre for Cancer Cell Reprogramming (CanCell), Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
[60]
Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK.
[61]
Institute of Medical Genetics, Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, UK.
[62]
DOI
10.1186/s13053-023-00263-3
PMID
37821984
发布时间
2024-03-20
- 浏览0
Hereditary cancer in clinical practice
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
